Search clinical trials for: BGB-A3055
Total 228 results
-
BeiGeneRecruitingSolid Tumor | Advanced Solid Tumor | Metastatic Solid TumorUnited States, France, Australia
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); BerGenBio ASATerminatedBrain and Central Nervous System TumorsUnited States
-
BeiGeneCompleted
-
BeiGeneCompletedHealthy VolunteersUnited States
-
BeiGeneCompletedMarginal Zone Lymphoma | MZLChina, Australia, Italy, France, New Zealand, Czechia, United Kingdom, United States, Korea, Republic of
-
BeiGeneCompletedCovid19United States, Mexico, Brazil, South Africa
-
BeiGeneMyriad Genetic Laboratories, Inc.CompletedSolid TumorsUnited States, Spain, United Kingdom, France, Australia, New Zealand
-
BeiGeneRecruitingRefractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Relapsed Follicular Lymphoma | Refractory Small Lymphocytic Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Diffuse Large B-cell Lymphoma | Transformed Non-Hodgkin Lymphoma | Relapsed... and other conditionsChina, Australia
-
BeiGeneCompletedFor Participants With Advanced Solid Tumors Failed With Previous Lines of TreatmentAustralia
-
BeiGeneCompleted
-
BeiGeneRecruitingMarginal Zone Lymphoma | Relapsed/Refractory Follicular LymphomaUnited States, Italy, Spain, China, United Kingdom, Australia, Israel, Korea, Republic of, France, Brazil, Ireland, Czechia, Romania, Argentina, Puerto Rico, Austria
-
BeiGeneTerminatedAdvanced Solid TumorsAustralia, Spain, New Zealand
-
BeiGeneCompletedSolid TumorsAustralia, New Zealand
-
Fudan UniversityRecruitingLimited Stage Small Cell Lung CancerChina
-
BeiGeneRecruitingLymphoma | Leukemia | Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Relapsed Chronic Lymphocytic LeukemiaChina
-
BeiGeneCompletedLocally Advanced or Metastatic Urothelial Bladder CancerKorea, Republic of, China
-
BeiGeneCompletedNot DeterminedAustralia, China
-
BeiGeneCompletedCutaneous T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Extranodal NK/T-cell Lymphoma, Nasal Type | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Peripheral... and other conditionsChina, Taiwan, Germany, France, Canada, Italy
-
BeiGeneCompletedClassical Hodgkin LymphomaChina
-
BeiGeneTerminatedMetastatic Castration-Resistant Prostate Cancer (mCRPC) | Homologous Recombination Deficiency (HRD)United States, Australia, Puerto Rico, Spain
-
Australia New Zealand Gynaecological Oncology GroupBeiGeneWithdrawn
-
BeiGeneNot yet recruitingAutoimmune Diseases | Healthy Volunteers | Healthy Subjects | Healthy Participants | Healthy Adult Participants
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, China, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
BeiGeneActive, not recruitingMature B-cell MalignanciesChina
-
BeiGeneWithdrawnHealthy VolunteersUnited States
-
BeiGeneRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelodysplastic/Myeloproliferative NeoplasmChina, United States, Australia, Spain, Korea, Republic of, New Zealand, Germany
-
BeiGeneRecruitingNSCLC | Non-small Cell Lung CancerJapan, United States, France, Mexico, Germany, Argentina, Brazil, Korea, Republic of, Turkey
-
BeiGeneSpringWorks Therapeutics, Inc.RecruitingSolid Tumor, AdultAustralia, United States
-
SpringWorks Therapeutics, Inc.Recruiting
-
BerGenBio ASATerminatedOvarian NeoplasmsKorea, Republic of, Singapore, United Kingdom, Norway
-
BeiGeneActive, not recruitingNonsmall Cell Lung Cancer, Stage IV | Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC)United States, China, Korea, Republic of, France, Spain, Australia, Austria
-
BeiGeneActive, not recruiting
-
BeiGeneRecruitingSolid Tumor | Advanced Solid TumorUnited States, New Zealand, Australia, China
-
BeiGeneEnrolling by invitationAdvanced MalignanciesChina, Taiwan, Turkey, Korea, Republic of
-
BeiGeneRecruitingAdvanced Solid TumorChina, United States, Australia, New Zealand, Korea, Republic of
-
BeiGeneCompletedAdvanced or Inoperable Gastric CancerUnited States, Hungary, Spain, China, Hong Kong, Japan, Australia, Taiwan, Belgium, Czechia, Singapore, France, Poland, United Kingdom, Romania, Russian Federation, Georgia
-
BeiGeneActive, not recruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma (HNSCC) | Nasopharyngeal Carcinoma (NPC)Canada, Australia, New Zealand, Korea, Republic of, United States, Malaysia, Thailand
-
BeiGeneRecruitingAdvanced Solid TumorsUnited States, Australia, Spain
-
BeiGeneCompletedAdvanced CancerUnited States, Taiwan, Australia, Korea, Republic of, New Zealand
-
BeiGeneRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaChina, Italy, Taiwan, Australia, Spain, Korea, Republic of, France, United Kingdom, Thailand, Canada, United States, Georgia, Singapore, Turkey
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
BeiGeneCompletedLymphoma | LeukemiaChina, Australia
-
BeiGeneRecruitingMSI-H/dMMR Solid TumorsChina
-
West China HospitalRecruiting
-
MapKure, LLCRecruitingSolid Tumor | B-Raf Mutation-Related TumorsUnited States, Australia
-
BeiGeneTerminatedNon Small Cell Lung CancerChina, Taiwan, Australia, United States
-
BeiGeneCompletedLimited Stage Small Cell Lung CancerChina, Korea, Republic of, United States
-
Sun Yat-sen UniversityRecruitingImmunotherapy | DMMR Colorectal Cancer | Anti PD-1China